• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News

News · March 29, 2022

Egg Medical hatches technology to shield health care workers from radiation

The Arden Hills company has landed $13 million in financing.  By Burl Gilyard Star Tribune MARCH 27, 2022 — 2:00PM A Twin Cities medtech startup, Egg Medical Inc., is building up sales of a new …

News · March 15, 2022

Egg Medical hatches $13M VC funding

March 4, 2022 By Annette Boyle Egg Medical Inc. secured a $13 million investment from TVM Capital Life Science to solve the Humpty-Dumpty problem that plagues interventional cardiology …

News · March 3, 2022

Egg Medical, Inc., Closes on $13 million Financing

Egg Medical, Inc., Closes on $13 million Financing Arden Hills, MN (March 3rd, 2022) — Egg Medical, Inc., a medical device company commercializing technologies to reduce scatter radiation exposure …

News · February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …

News · February 1, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

centogene

Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …

News · February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

centogene

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 51
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

March 17, 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

February 23, 2023

Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ

February 21, 2023

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

February 1, 2023

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

August 1, 2022

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact